Approfondimenti generali
American Society of Clinical Oncology (ASCO) [Apri]
Neoplasie della mammella, Linee Guida AIOM, 2018 [Apri]
ESMO Clinical Practice Guidelines: Breast Cancer [Apri] A service of the U.S. National Institutes of Health [Apri]
Referenze bibliografiche specifiche
Caprarica R, et al. Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives. Ther Adv Med Oncol 2019;11 [Apri]
Hayes D, et al. Further Progress for Patients with Breast Cancer.N Engl J Med 2019;380:676-677 [Apri]
Powell TM, et al. Residual Disease after Neoadjuvant Therapy - Developing Drugs for High-Risk Early Breast Cancer. N Engl J Med 2019;380:612-615 [Apri]